Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Withdrawn2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (25.0%)
N/A3 (75.0%)

Trials by Status

completed125%
terminated125%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

Depodur vs Fentanyl Infusion for Post-C/S Analgesia

NCT00762554
terminatedphase_4

Combination of Peripheral Nerve Block and DepoDur in Total Knee Joint Replacement

NCT00895531
completednot_applicable

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

NCT00335517
withdrawnnot_applicable

Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)

NCT00456638

Clinical Trials (4)

Showing 4 of 4 trials
NCT00762554Not Applicable

Depodur vs Fentanyl Infusion for Post-C/S Analgesia

Withdrawn
NCT00895531Phase 4

Combination of Peripheral Nerve Block and DepoDur in Total Knee Joint Replacement

Terminated
NCT00335517Not Applicable

Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients

Completed
NCT00456638Not Applicable

Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4